281 reports of this reaction
2.8% of all POVIDONE IODINE reports
#4 most reported adverse reaction
TOXIC ANTERIOR SEGMENT SYNDROME is the #4 most commonly reported adverse reaction for POVIDONE IODINE, manufactured by Alcon Laboratories, Inc.. There are 281 FDA adverse event reports linking POVIDONE IODINE to TOXIC ANTERIOR SEGMENT SYNDROME. This represents approximately 2.8% of all 10,103 adverse event reports for this drug.
Patients taking POVIDONE IODINE who experience toxic anterior segment syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TOXIC ANTERIOR SEGMENT SYNDROME is a less commonly reported adverse event for POVIDONE IODINE, but still significant enough to appear in the safety profile.
In addition to toxic anterior segment syndrome, the following adverse reactions have been reported for POVIDONE IODINE:
The following drugs have also been linked to toxic anterior segment syndrome in FDA adverse event reports:
TOXIC ANTERIOR SEGMENT SYNDROME has been reported as an adverse event in 281 FDA reports for POVIDONE IODINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
TOXIC ANTERIOR SEGMENT SYNDROME accounts for approximately 2.8% of all adverse event reports for POVIDONE IODINE, making it a notable side effect.
If you experience toxic anterior segment syndrome while taking POVIDONE IODINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.